Transcatheter Interventions Online 2022 - On Demand
Published: 09 March 2022
59m 54sPart 3 | Session 2 Session 3.3: Live Cases and Discussion
1h 3m 33sPart 3 | Session 4 Session 3.4: Debates
1h 1m 7sPart 1 | Session 1 Session 1.1: Next Level Structural Heart Interventions Nicolas M Van Mieghem, Kendra J Grubb, Lars Søndergaard, Azeem Latib, David Hildick-Smith
1h 2m 19sPart 1 | Session 2 Session 1.2: Live Cases and Discussion Lars Søndergaard, Ole De Backer, Holger Thiele, Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, David Hildick-Smith, Mohamed Abdel-Wahab
45m 54sPart 1 | Session 3 Symposium: Optimising Outcomes for the TAVI Patient: Key Considerations for First Valve Choice and Implantation Techniques Didier Tchétché, Lars Søndergaard, Ran Kornowski, Douglas G Fraser
59m 47sPart 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI Kendra J Grubb, Didier Tchétché, Roxana Mehran, David Hildick-Smith, Lars Søndergaard
1h 2m 44sPart 1 | Session 5 Session 1.4: Live Cases and Discussions Nicolas M Van Mieghem, Susheel Kodali, Kendra J Grubb, Roxana Mehran, Didier Tchétché, David Hildick-Smith, Lars Søndergaard
44m 31sPart 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC Ole De Backer, Dabit Arzamendi
48m 20sPart 1 | Session 7 BREAKOUT: Key Considerations to Ensure Long-Term Patients’ Outcomes: When Anatomy, Engineering and Clinical Practice Come Together David Smith, Andrew Cook
1h 1m 36sPart 2 | Session 1 Session 2.1: Strategies for Calcified Coronary Lesions Anno 2022 Ajay J Kirtane, Joost Daemen, Margaret B McEntegart, Azeem Latib, Didier Tchétché
57m 43sPart 2 | Session 2 Session 2.2: Live Cases and Discussion George D Dangas, Holger Thiele, Ajay J Kirtane, Joost Daemen, Margaret B McEntegart, Azeem Latib, Didier Tchétché, Annapoorna Kini
45m 25sPart 2 | Session 3 Symposium: Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success Ole De Backer, Darren Mylotte, Colum Owens, Mark Spence
1h 1m 32sPart 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme Roxana Mehran, Ajay J Kirtane, Holger Thiele, David Hildick-Smith, Margaret B McEntegart
56m 37sPart 2 | Session 5 Session 2.4: Live Cases and Discussion Roxana Mehran, David Hildick-Smith, Holger Thiele, Nicolas M Van Mieghem, Ajay J Kirtane, Margaret B McEntegart, Roberto Diletti
56m 12sPart 2 | Session 6 BREAKOUT: Innovations in Treating Complex PCI: The Role of Orbital Atherectomy Nicolas M Van Mieghem, Amir Kaki, Kambis Mashayekhi
45m 31sPart 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How? Ziad A Ali, Joost Daemen, Zsolt Piroth
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Day One: Structural Heart Disease
Day Two: Coronary Heart Disease: High Risk & Complex PCI
Day Three: Debates and Controversies
Director and Physician-in-Chief
Dr Fuster completed his medical degree at Barcelona University in 1967 and then pursued an internship at Hospital Clínic de Barcelona. In 1971, he attended the University of Edinburgh as a research fellow in cardiovascular disease for three years under the tutelage of Desmond Julian and Harold Sheehan. He earned his PhD degree at Edinburgh University with his thesis focussing on platelet factor 4.
Following his fellowship in Edinburgh, Valentin spent time as a resident at the Mayo Graduate School of Medicine in Minnesota, later becoming the school’s Professor of Medicine and Consultant in Cardiology at the age of 39.
Valentin spent 10 years at the Mayo Graduate School of Medicine, following which he became Chief of Cardiology at Mount Sinai School of Medicine, New York.
In 1991, Valentin was made full Professor of Medicine at Harvard Medical School and Chief of Cardiology at Massachusetts General Hospital. He was one of the first to appreciate…
Professor of Medicine, Cardiology and Professor of Population Health Science and Policy
Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a globally respected data and clinical coordination centre to support large, multicentre, multinational clinical trials designed to help improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.
Roxana serves on editorial board of multiple peer reviewed journals, including …
Nicolas M Van Mieghem
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Kendra J Grubb
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.
A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment.